P&G to challenge Indian ban on Vicks Action 500 Extra

March 15, 2016 6:32 PM

26 0

MUMBAI U.S. consumer health group Procter & Gamble's Indian business plans to challenge a government ban on its cough-and-cold medicine Vicks Action 500 Extra, citing potential health risks.

Procter & Gamble Hygiene and Health Care said that while it had stopped selling the product, it was evaluating all options to challenge the ban.

Also read: Sanofi invests 170 million euros in French vaccines facility

Read more

To category page